4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-113342
Options or other derivatives
- Chief Medical Officer acquired 450,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Berkowitz Noah · Chief Medical Officer
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-30 | Grant or award : show line 1 in the form Stock Options (Right to Buy) | +135,000 | 135,000 | D |
| 2026-09-30 | Grant or award : show line 2 in the form Restricted Stock Units | +180,000 | 180,000 | D |
| 2026-09-30 | Grant or award : show line 3 in the form Performance Stock Units | +135,000 | 135,000 | D |
Loading xslF345X06/tm2626734-2_4seq1.xml…